Elite Pharmaceuticals Inc (ELTP)

[mts]

The FDA is in a face saving mode. They have egg on their face from PFE and Embeda and really did themselves in on Zohydro for which even Congress got on their case. The FDA will time this so Embeda will be first to market. PFE has invested millions and millions of dollars beyond what ELTP has spent or ever will spend to get El200 to market. PFE shareholders would be filing lawsuits if they knew what happened to Embeda just to get it to market and how much they have spent. The FDA it appears is giving free passes for Embeda and Zohydro. Then ELTP will be up next. Our product is better, can be formulated in many ways, and can grossly undersell PFE . I am glad Embeda will go on the market first so we can see what the price structure is going to be. What ever it is Embeda will not last long on the market or PFE is going to have to lose a lot more money than they already have just to keep it on the market which they probably will have to do unless the CEO wants to lose his job. The only good thing PFE can say about Embeda is that they can pass the hot potato to Purdue and let them deal with all the lawsuits.